Alli Diet Pill is a Supplement?

As I am sure you have already noticed I am currently doing a great deal of research on diet pills. The reason for this is because as a personal trainer I know that one of the most popular New Year’s resolutions made by Americans is to loose weight.

Therefore, it is not surprising that both gym membership sales and diet pill sales peak in the month of January. As “diet season” begins we are bombarded by “diet supplement”…aka…diet pill advertisements.

Currently, one of the most popular and heavily advertised, “diet supplement” on the market is the diet pill Alli.

So, I did some research on this new miracle drug marketed by the pharmaceutical giant GlaxoSmithKline.  The following is a short list of my findings:

1. Alli is an over-the-counter weight loss “supplement” whose key component is Xenical, a prescription medication…….
2. The diet pills, Alli (Orlistat) and the prescription medication Xenical (Orlistat) are manufactured by two different pharmaceutical companies.
3. Xenical and Alli have the same side effects (or “treatment effects” as they are called by the makers of Alli) which include, but are not limited to, oily flatulence and uncontrollable bowl movements.
4. The only real difference between the two products is their recommended daily dosage:

Xenical = (120 mg) three times a day
Alli = (60 mg) three times a day

What amazes me more than the ingenious way GlaxoSmithKline has managed to maneuver its product past FDA approval and sell it to the general public as a “new”, miracle, over-the- counter weight loss “supplement” when Roche Laboratories, the makers of Xenical, could not is the fact that we, the consumers, are not in the least bit troubled by the dangerous and humiliating side effects of these weight loss “supplements” as is reflected through their sales.

But, then again, why am I being so uptight about a few innocent “treatment effects”?

Doesn’t everybody poop?

Enjoy this post? Share it!

If you enjoyed this post, please consider Leaving a Comment, Subscribing by Email, or Subscribing to the RSS feed to have future articles delivered to your feed reader.

Subscribe via Email